Tag: ReCell

Innovation, Research

Avita Medical’s ReCell technology safe, effective for patients suffering with depigmented skin lesions

July 8, 2015

Via: The Medical News

Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced that statistically significant data from a randomized controlled study demonstrated that its single-use autologous cell suspension technology ReCell® […]